In 2002, Rhode Island Hospital received an $8.2 million grant from the National Institutes of Health Centers of Biomedical Research Excellence (COBRE) to establish the COBRE Center for Cancer Research Development at Rhode Island Hospital (COBRE CCRD).
The mission of the Center for Cancer Research Development is to create, interpret and apply new knowledge based on original, collaborative, multidisciplinary laboratory studies of the cellular and molecular pathways leading to carcinoma. Such knowledge will be generated in an environment that fosters career development of promising junior investigators and employs cutting-edge methodology and applications to further our understanding of the cancer process. Basic knowledge gained will be used to design and implement novel diagnostic and treatment protocols to benefit Center patients and the community.
The COBRE CCRD’s administrative core directs the center’s activities including grantwriting workshops, symposia, seminars and bi-annual advisory committee meetings. The proteomics core provides cutting-edge biotechnology for analyzing how proteins change when a normal cells becomes cancerous. The goal is to find new markers for early detection and diagnosis of cancer. The molecular pathology core provides a tissue bank for storing and cataloging valuable human and animal tissues and services such as laser capture micro-dissection.
Learn more about the Future of Cancer Research in Rhode Island.
(PDF, 947K; This requires Adobe Acrobat Reader. If you don't have it installed you can download it now for free.)
This website was made possible by NIH Grant Number RR-P20 RR17695 from the Institutional Development Award (IDeA) Program of the National Center for Research Resources/Center of Biological Research Excellence (COBRE).
One Hoppin Street • Providence, RI 02903
Phone: 401-444-7237 • email: AGarcia3@lifespan.org |
